India may, in the next six or seven months, make history as the first country to issue a form of a male contraceptive.
According to Dr. R.S Sharma, the drug is ready and is only waiting for a few more regulatory approvals, including the one from bodies like the Drug Controller General of India. (DCGI)
The contraceptive is meant to replace vasectomy, and it is expected to last for about 13 years before losing its power.
Also known as Reversible Inhibition of Sperm Under Guidance (RISUG), this contraceptive is made of the Styrene Maleic Anhydride compound
During some 300 clinical trials, it registered a 97.3 % success rate with no reported side effects.